phosphorylethanolamine has been researched along with Idiopathic Parkinson Disease in 2 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ross, BM | 1 |
Mamalias, N | 1 |
Moszczynska, A | 1 |
Rajput, AH | 1 |
Kish, SJ | 2 |
Rajput, A | 1 |
Gilbert, J | 1 |
Rozdilsky, B | 1 |
Chang, LJ | 1 |
Shannak, K | 1 |
Hornykiewicz, O | 1 |
2 other studies available for phosphorylethanolamine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Cell Membrane; Choline-Phosphate Cytidylyltransferase; Cytidine Diphosphate | 2001 |
Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss.
Topics: Brain Chemistry; Corpus Striatum; Dopamine; Ethanolamines; gamma-Aminobutyric Acid; Glutamate Decarb | 1986 |